{{Rsnum
|rsid=2199936
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Chromosome=7
|Orientation=plus
|position=79651453
|Assembly=GRCh37.p2
|GenomeBuild=37.2
|dbSNPBuild=134
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 1.6 | 14.3 | 84.1
| HCB | 9.8 | 34.1 | 56.1
| JPT | 7.5 | 50.0 | 42.5
| YRI | 1.7 | 15.5 | 82.8
| ASW | 0.0 | 0.0 | 0.0
| CHB | 9.8 | 34.1 | 56.1
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=20884846
|Trait=None
|Title=Multiple Genetic Loci Influence Serum Urate And Their Relationship With Gout and Cardiovascular Disease Risk Factors
|RiskAllele=A
|Pval=1E-75
|OR=18.08
|ORtxt=[16.16-20.00] umol/l increase
|OA=1
}}

{{PMID Auto GWAS
|PMID=21943158
|Trait=None
|Title=Genetic variants in LPL, OASL and TOMM40/APOE-C1-C2-C4 genes are associated with multiple cardiovascular-related traits.
|RiskAllele=A
|Pval=2E-17
|OR=0.1880
|ORtxt=[0.14-0.23] umol/l increase
|OA=1
}}

{{PMID|19503597|OA=1
}} Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations.

{{PMID Auto GWAS
  |PMID=23118302
  |Trait=Lipoprotein-associated phospholipase A2 activity change in response to statin therapy
  |Title=Genome-wide association study evaluating lipoprotein-associated phospholipase A2 mass and activity at baseline and after rosuvastatin therapy.
  |RiskAllele=A
  |Pval=2E-10
  |OR=2.80
  |ORtxt=[1.82-3.78] percent decrease
  }}

{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}